The global post-operative wound treatment market size is likely to exhibit growth at a CAGR of 4.8% in the forecast period from 2022 to 2032. It is expected to be valued at US$ 21.7 Billion in 2022 and US$ 25.1 Billion in 2032. Rising prevalence of chronic diseases and the increasing number of surgical cases are anticipated to propel the demand for post-operative wound treatment options in future.
| Report Attribute | Details |
| Post-Operative Wound Treatment Market Estimated Base Year Value (2021) | US$ 20.3 Billion |
| Post-Operative Wound Treatment Market Expected Market Value (2022) | US$ 21.7 Billion |
| Post-Operative Wound Treatment Market Anticipated Forecast Value (2032) | US$ 25.1 Billion |
| Post-Operative Wound Treatment Market Projected Growth Rate (2022-2032) | 4.8% CAGR |
Post-operative or post-surgical wound care refers to the monitoring, protection, and cleansing of the skin to enable quick wound healing and prevent infections. The rising number of awareness programs conducted by government bodies to educate the masses about the availability of advanced wound healing products is expected to drive the market.
Rising adoption of bioactive therapies, such as skin substitutes by many healthcare institutions worldwide is set to help in the rapid treatment of late-stage wounds. Numerous companies are mainly focusing on the development of dermal substitutes, allograft, cell-based therapies, nanofiber, and xenograft to meet the unmet need for effective wound treatment.
In March 2022, for instance, the Journal of Bone & Joint Surgery published that Conditionally Essential Amino Acids (CEAA), if given with dietary supplements to patients recovering from fracture fixation surgery, can prevent skeletal muscle wasting. It can also help in reducing complications that may occur post-surgery. Thus, the surging number of research and development activities conducted by multiple organizations is set to bode well for the market.
Increasing cases of diabetes and diabetic foot ulcers is anticipated to bode well for the post-operative wound treatment market growth in the evaluation period. As per the American Diabetes Association, around 37.3 million Americans were suffering from diabetes in 2019 and every year, nearly 1.4 million Americans are diagnosed with the disease. This trend is likely to continue in future, thereby driving the market.
The surging prevalence of chronic conditions that often result in traumatic, acute, and surgical wounds is another significant factor that is expected to propel the market. The rising adoption of regenerative medicines for the management of post-operative wounds is also anticipated to push the market.
The high cost of innovative treatment options may hamper the sales of post-operative wound treatment products, especially in emerging economies. Physicians and patients present in these countries often prefer relatively low cost wound management products. Even though many companies are developing and distributing bioengineered dressings, healthcare professionals and patients are mainly preferring basic and conventional products backed by their cost-effectiveness.
The presence of a well-established healthcare infrastructure in the U.S. is estimated to augment the North America post-operative wound treatment market share by 2032. The rising number of surgical procedures performed in this region owing to the high geriatric population is anticipated to aid the growth.
The presence of a well-established healthcare infrastructure in the U.S. is estimated to augment the North America post-operative wound treatment market share by 2032. The rising number of surgical procedures performed in this region owing to the high geriatric population is anticipated to aid the growth.
According to the U.S. Census Bureau, in 2019, there were approximately 54.1 million senior citizens belonging to the age group of 65 years and above in the country, while in 2010, it was 40.3 million. These numbers are expected to grow at a fast pace in the future years, thereby boosting the market across North America.
The rising number of Ambulatory Surgical Centers (ASCs) in China and India owing to the ever-increasing population is expected to augur well for the Asia Pacific post-operative wound treatment market growth. ASCs provide a wide range of affordable services, such as preventive procedures, diagnostics, and surgical care.
Various surgeries for orthopedics, urology, and pain management are also performed in these ASCs. In addition to that, Gastro-Intestinal (GI)-related surgeries, alternative plastic surgeries, reconstructive, and restorative surgeries are provided in ASCs at a low cost. Spurred by the aforementioned factors, the market is set to grow at a rapid pace in Asia Pacific.
Some of the prominent companies present in the global post-operative wound treatment market include Medtronic, Smith & Nephew, Ethicon (Johnson & Johnson), Mölnlycke Health Care AB, 3M, ConvaTec Group PLC, Derma Sciences Inc. (Integra LifeSciences), Baxter International, Coloplast Corp., and URGO Medical among others.
The global market is highly fragmented with the presence of various large-scale companies. These players are increasingly focusing on mergers, acquisitions, and collaboration strategies to expand their portfolios. A few other companies are striving to invest huge sums in capacity expansions and research and development activities to intensify the degree of competition, as well as competitive rivalry.
| Report Attribute | Details |
| Growth Rate | CAGR of 4.8% from 2022 to 2032 |
| Base Year for Estimation | 2021 |
| Historical Data | 2015-2020 |
| Forecast Period | 2022-2032 |
| Quantitative Units | Revenue in USD Billion, Volume in Kilotons and CAGR from 2022-2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered |
|
| Regions Covered |
|
| Key Countries Profiled |
|
| Key Companies Profiled |
|
| Customization | Available Upon Request |
By Product Type:
By Distribution Channel:
By Region:
The global post-operative wound treatment market is projected to reach US$ 25.1 Billion by 2032.
North America is set to be the most lucrative for the post-operative wound treatment market growth.
Medtronic, Smith & Nephew, Ethicon (Johnson & Johnson), Mölnlycke Health Care AB, 3M, ConvaTec Group PLC, and Baxter International are some of the dominant providers of post-operative wound treatment.
Explore Similar Insights
Post-Operative Wound Treatment Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
